Jagdip S Sidhu

Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes Mellitus

Jagdip S Sidhu, Zoltán Káposzta, Hugh S. Markus et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 252 citations

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

Jagdip S Sidhu, Dahlia Cowan, Juan‐Carlos Kaski · Journal of the American College of Cardiology · 2003 · 196 citations

Metabolic Syndrome, Thrombosis, C-reactive Protein +13

Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus**The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of this report.

Jagdip S Sidhu, Dahlia Cowan, Juan Carlos Kaski · The American Journal of Cardiology · 2004 · 75 citations

Endothelial Cell Pathobiology, Metabolic Syndrome, Vascular Disease +9

Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease

Jagdip S Sidhu, Dahlia Cowan, J. Adam Tooze et al. · American Heart Journal · 2004 · 71 citations

Metabolic Syndrome, Thrombosis, Cardiovascular Disease +11

A rapid and reproducible on line automated technique to determine endothelial function

Jagdip S Sidhu · Heart · 2002 · 46 citations · Full text